Yield10 Bioscience Inc (YTEN.OQ)
YTEN.OQ on NASDAQ Stock Exchange Capital Market
1.01USD
6:53pm GMT
1.01USD
6:53pm GMT
Change (% chg)
$-0.07 (-6.48%)
$-0.07 (-6.48%)
Prev Close
$1.08
$1.08
Open
$1.06
$1.06
Day's High
$1.13
$1.13
Day's Low
$0.99
$0.99
Volume
10,931
10,931
Avg. Vol
10,124
10,124
52-wk High
$4.35
$4.35
52-wk Low
$0.92
$0.92
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- ownership
- filings
- deals
- private equity
- third-party document and information retrieval
- estimates
- fundamentals
- economics
- events
- news
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
| Name | Age | Since | Current Position |
|---|---|---|---|
Robert Van Nostrand |
61 | 2013 | Chairman of the Board, Independent Director |
Oliver Peoples |
58 | 2016 | President, Chief Executive Officer, Director |
Charles Haaser |
60 | 2016 | Chief Accounting Officer, Vice President - Finance |
Lynne Brum |
52 | 2016 | Vice President - Planning and Communications |
Kristi Snell |
2016 | Chief Science Officer, Vice President - Research |